Trials / Unknown
UnknownNCT02029014
Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
Evaluation of Safety and Efficacy of the New Generation of Left Appendage Closure With the LAmbre Device in AF Patients Not Suitable for Use of Warfarin
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 154 (estimated)
- Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the efficacy, safety and performance of LAmbre left atrial appendage closure system in patients with non-valvular atrial fibrillation who cannot be treated with Warfarin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LAA closure system |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-03-01
- Completion
- 2016-07-01
- First posted
- 2014-01-07
- Last updated
- 2014-03-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02029014. Inclusion in this directory is not an endorsement.